Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ido

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Ryoikibetsu Shokogun Shirizu|February 1, 1994
[Chronic recurrent pulmonary embolism]A Ido, E Sakai
Methods in Molecular Medicine|March 11, 2011
Gene Targeting to Hepatomas (AFP)S Tsuruta, A Ido, S Nagataki
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|December 1, 1995
[Human alpha-fetoprotein transcriptional regulatory regions: application to gene therapy]T Tamaoki, T Hashimoto, A Ido
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2002
[Tumor dormancy therapy for hepatocellular carcinoma]T Hori, A Ido, H Tsubouchi
Developmental Biology|May 1, 1994
Activation of ATBF1, a multiple-homeodomain zinc-finger gene, during neuronal differentiation of murine embryonal carcinoma cellsA Ido, Y Miura, T Tamaoki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 1, 1988
[A case of coronary artery disease probably elicited by mediastinal radiation]M Horimoto, T Igarashi, Y Masaki, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 17, 2001
Coronary sinus occlusion enhances coronary collateral flow and reduces subendocardial ischemiaA Ido, N Hasebe, H Matsuhashi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 1995
[Direct sequencing for PCR products]M Daikoku, A Ido, K Nakata, et al.
The Journal of Biological Chemistry|January 15, 1992
A possible mechanism of inverse developmental regulation of alpha-fetoprotein and albumin genes. Studies with epidermal growth factor and phorbol esterK Nakata, M Motomura, H Nakabayashi, et al.
Clinical Pharmacology and Therapeutics|January 25, 2017
Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 TherapiesY Komaki, F Komaki, A Yamada, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Ryoikibetsu Shokogun Shirizu|February 1, 1994
[Chronic recurrent pulmonary embolism]A Ido, E Sakai
Methods in Molecular Medicine|March 11, 2011
Gene Targeting to Hepatomas (AFP)S Tsuruta, A Ido, S Nagataki
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|December 1, 1995
[Human alpha-fetoprotein transcriptional regulatory regions: application to gene therapy]T Tamaoki, T Hashimoto, A Ido
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2002
[Tumor dormancy therapy for hepatocellular carcinoma]T Hori, A Ido, H Tsubouchi
Developmental Biology|May 1, 1994
Activation of ATBF1, a multiple-homeodomain zinc-finger gene, during neuronal differentiation of murine embryonal carcinoma cellsA Ido, Y Miura, T Tamaoki
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 1, 1988
[A case of coronary artery disease probably elicited by mediastinal radiation]M Horimoto, T Igarashi, Y Masaki, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 17, 2001
Coronary sinus occlusion enhances coronary collateral flow and reduces subendocardial ischemiaA Ido, N Hasebe, H Matsuhashi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 1, 1995
[Direct sequencing for PCR products]M Daikoku, A Ido, K Nakata, et al.
The Journal of Biological Chemistry|January 15, 1992
A possible mechanism of inverse developmental regulation of alpha-fetoprotein and albumin genes. Studies with epidermal growth factor and phorbol esterK Nakata, M Motomura, H Nakabayashi, et al.
Clinical Pharmacology and Therapeutics|January 25, 2017
Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 TherapiesY Komaki, F Komaki, A Yamada, et al.
Pageof 6